Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

NCT00031837 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Thromboembolism

Interventions

DRUG: dalteparin
DRUG: gemcitabine hydrochloride
PROCEDURE: quality-of-life assessment

Sponsor

Gary Morrow

Collaborators

[object Object]